US Patent 9623120 Recombinant adeno-associated vectors for targeted treatment
Patent 9623120 was granted and assigned to City of Hope on April, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9623120 Recombinant adeno-associated vectors for targeted treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.